PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
10-Sep-2020 Merck Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion Merck
10-Sep-2020 HealthTech Innovation Days Announce Details of Conference Program & Attendees HealthTech
10-Sep-2020 ECCRT and IDDI establish partnership for continuous development of IDDI global team members International Drug Development Institute (IDDI)
10-Sep-2020 PTC Therapeutics Launches PTC PINPOINT - A Genetic Testing Program for Individuals Suspected of Having Neurotransmitter Disorders PTC Therapeutics, Inc.
10-Sep-2020 Norfolk Hospital Staff Embrace Technology for Virtual Training Norfolk & Norwich University Hospitals
10-Sep-2020 Clinical trials company urges public to continue involvement in research despite Oxford COVID-19 trial being halted Innovative Trials
10-Sep-2020 Theragnostics Signs Agreement with Summit Biomedical Imaging Enabling the Development of Novel Fluorescence-Based Cancer Diagnostics Theragnostics
10-Sep-2020 RDIF and Landsteiner Scientific agree to supply 32 million doses of Sputnik V vaccine to Mexico Russian Direct Investment Fund
10-Sep-2020 Orgenesis CEO to Participate in Webinar Panel on “New Approaches to COVID-19” on Thursday, September 10th Orgenesis
10-Sep-2020 Kallik joins life sciences organisation Medilink West Midlands as newest patron to help drive growth and collaboration in post-COVID times Kallik
10-Sep-2020 AstraZeneca aims to transform cancer treatment and advance clinical practice with data presented at ESMO 2020 AstraZeneca
10-Sep-2020 Avillion announces positive top-line results of Phase 2 trial of sonelokinab (M1095), an anti-IL-17 A/F Nanobody®, in chronic psoriasis Avillion
08-Sep-2020 HRA PHARMA RARE DISEASES: FIRST PROSPECTIVE STUDY CONFIRMS THAT METYRAPONE EFFECTIVELY LOWERS UFC LEVELS IN PATIENTS WITH ENDOGENOUS CUSHING’S SYNDROME HRA Pharma
07-Sep-2020 Farxiga demonstrated unprecedented reduction in the risk of kidney failure and cardiovascular or renal death in patients with chronic kidney disease in the Phase III DAPA-CKD trial AstraZeneca
07-Sep-2020 Signifier Medical Technologies appoints Philip Hess, former President & CEO of Bose Corporation, as Chief Operating Officer Signifier Medical Technologies
07-Sep-2020 Hansa Biopharma ger uppdatering om kliniska program Hansa Biopharma
07-Sep-2020 PAGE & PAGE AND PARTNERS ANNOUNCES: NEW PARTNERS, NEW LONDON OFFICE, CLIENTS WINS AND RECRUITMENT DRIVE DURING PANDEMIC Page & Page and Partners
07-Sep-2020 Coulter Partners secures Chief Financial Officer for Saniona Coulter Partners
07-Sep-2020 More engineers needed to deliver high tech healthcare – IMechE report The National Health Service
07-Sep-2020 AskBio Awarded £2m Scottish Enterprise R&D Grant to Help Reduce Barriers to Mainstream Gene Therapy Asklepios BioPharmaceutical, Inc.